Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.37 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15028119 | 1.00 | NPC1 (0.37) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL2230473 | 0.88 | NPC1 (0.32) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL30040842 | 0.85 | KEAP1 (0.46) | ALDH1A1L3MBTL1CRHBPCRHR2KEAP1 | |
| SCHEMBL29709221 | 0.85 | KEAP1 (0.46) | ALDH1A1L3MBTL1CRHBPCRHR2KEAP1 | |
| SCHEMBL961673 | 0.85 | KEAP1 (0.46) | ALDH1A1L3MBTL1CRHBPCRHR2KEAP1 | |
| SCHEMBL15028276 | 0.83 | TRPA1 (0.35) | ALDH1A1L3MBTL1CRHBPCRHR2KEAP1 | |
| SCHEMBL12200531 | 0.83 | LIPG (0.40) | CRHBPCRHR2KEAP1NFE2L2 | |
| SCHEMBL12127199 | 0.81 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1CRHBPCRHR2KEAP1 | |
| SCHEMBL14820964 | 0.81 | LPL (0.33) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 | |
| SCHEMBL4196550 | 0.81 | NPC1 (0.32) | NPC1ALDH1A1PLA2G1BNFKB1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2665691-B1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND IMAGE DISPLAY DEVICE | CANON KK (JP) | 2020-02-12 | — | — | EP | disclosed |
| US-9240554-B2 | Organic compound, organic electroluminescence element, and image display device | CANON KABUSHIKI KAISHA (JP) | 2016-01-19 | — | — | US | disclosed |
| US-9240554-B2 | Organic compound, organic electroluminescence element, and image display device | CANON KABUSHIKI KAISHA (JP) | 2016-01-19 | — | — | US | disclosed |
| EP-2464616-B1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME | CANON KK (JP) | 2014-10-29 | — | — | EP | disclosed |
| US-20130300638-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-11-14 | — | — | US | disclosed |
| US-20130300638-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-11-14 | — | — | US | disclosed |
| WO-2012098793-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-07-26 | — | — | WO | disclosed |
| US-20110148292-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110148292-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-06-23 | — | — | US | disclosed |
| US-7932592-B2 | Exhibits a light emission color with significantly high purity , highly efficient, highly luminant, and long-lived light emission; high glass transition temperature, heat stability and superior durability | CANON KABUSHIKI KAISHA (JP) | 2011-04-26 | — | — | US | disclosed |
| WO-2011018886-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-02-17 | — | — | WO | disclosed |
| US-20100123390-A1 | LIGHT-EMITTING DEVICE, IMAGE DISPLAY APPARATUS, AND NOVEL ORGANIC COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2010-05-20 | — | — | US | disclosed |
| US-20100123390-A1 | LIGHT-EMITTING DEVICE, IMAGE DISPLAY APPARATUS, AND NOVEL ORGANIC COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2010-05-20 | — | — | US | disclosed |
| US-20080124577-A1 | Exhibits a light emission color with significantly high purity , highly efficient, highly luminant, and long-lived light emission; high glass transition temperature, heat stability and superior durability | CANON KABUSHIKI KAISHA (JP) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100123390-A1 | LIGHT-EMITTING DEVICE, IMAGE DISPLAY APPARATUS, AND NOVEL ORGANIC COMPOUND | OCIAD1, OCIAD2, OR51E2 | NPC1 1455/4885ALDH1A1 163/4885PLA2G1B 4133/4885 |
| US-20110148292-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME | RPS24, OR10J3, ORC3 | NPC1 2584/4885ALDH1A1 600/4885PLA2G1B 4562/4885 |
| US-20080124577-A1 | Exhibits a light emission color with significantly high purity , highly efficient, highly luminant, and long-lived light emission; high glass transition temperature, heat stability and superior durability | LEF1, MAP1LC3A, HSF1 | NPC1 3297/4885ALDH1A1 726/4885PLA2G1B 3369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.